X-57331760-G-A
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2
The NM_174912.4(FAAH2):c.575G>A(p.Arg192Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000455 in 1,209,645 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 23 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_174912.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FAAH2 | NM_174912.4 | c.575G>A | p.Arg192Gln | missense_variant | 4/11 | ENST00000374900.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FAAH2 | ENST00000374900.5 | c.575G>A | p.Arg192Gln | missense_variant | 4/11 | 1 | NM_174912.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000628 AC: 7AN: 111533Hom.: 0 Cov.: 22 AF XY: 0.000148 AC XY: 5AN XY: 33713
GnomAD3 exomes AF: 0.0000601 AC: 11AN: 183101Hom.: 0 AF XY: 0.0000591 AC XY: 4AN XY: 67637
GnomAD4 exome AF: 0.0000437 AC: 48AN: 1098068Hom.: 0 Cov.: 30 AF XY: 0.0000495 AC XY: 18AN XY: 363456
GnomAD4 genome AF: 0.0000627 AC: 7AN: 111577Hom.: 0 Cov.: 22 AF XY: 0.000148 AC XY: 5AN XY: 33767
ClinVar
Submissions by phenotype
not specified Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 26, 2021 | The c.575G>A (p.R192Q) alteration is located in exon 4 (coding exon 4) of the FAAH2 gene. This alteration results from a G to A substitution at nucleotide position 575, causing the arginine (R) at amino acid position 192 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Likely benign, criteria provided, single submitter | clinical testing | Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia | Nov 06, 2015 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at